NOAC Stroke-Protection Benefits in AF; Abrupt Spike in Early Thrombosis With HeartMate II LVAD; Cardiac Device Deactivation; CABG Trumps PCI for Survival in CAD Even Without Diabetes

For the week ending December 6, 2013, we discuss the following top cardiology news from heartwire:

•  'New' Oral Anticoagulant Stroke-Protection Benefits in AF Cut Across Subgroups in Meta-Analysis

•  Abrupt Spike in Early Thrombosis With HeartMate II LVAD

•  Cardiac Device Deactivation Remains a Much-Delayed (and Thorny) Topic

•  CABG Trumps PCI for Survival in CAD Even Without Diabetes

And also, in brief:

•  Few See Renewed Role for Rosiglitazone in Diabetes

•  JAMA Weighs In on CVD Guidance, Statins in Primary Prevention

© 2013  WebMD, LLC

Cite this: NOAC Stroke-Protection Benefits in AF; Abrupt Spike in Early Thrombosis With HeartMate II LVAD; Cardiac Device Deactivation; CABG Trumps PCI for Survival in CAD Even Without Diabetes - Medscape - Dec 06, 2013.